مقایسه اثربخشی طرحواره درمانی با ذهن آگاهی مبتنی بر کاهش استرس بر خستگی بیماران خودایمنی مبتلا به میاستنی گراویس

Arntz, A., Jacob, G. A., Lee, C. W., Brand-de Wilde, O. M., Fassbinder, E., Harper, R. P., ... & Farrell, J. M. (2022). Effectiveness of Predominantly Group Schema Therapy and Combined Individual and Group Schema Therapy for Borderline Personality Disorder: A Randomized Clinical Trial. JAMA psychiatry, 79 (4), 287-299. https://doi.org/10.1001/jamapsychiatry.2022.0010

Arntz, A., Rijkeboer, M., Chan, E., Fassbinder, E., Karaosmanoglu, A., Lee, C. W., & Panzeri, M. (2021). Towards a reformulated theory underlying schema therapy: Position paper of an international workgroup. Cognitive Therapy and Research, 45 (6), 1007-1020. https://doi.org/10.1007/s10608-021-10209-5

Ayres, A., Winckler, P. B., Jacinto-Scudeiro, L. A., Rech, R. S., Padovani, M. M. P., Jotz, G. P., & Olchik, M. R. (2022). Speech characteristics in individuals with myasthenia gravis: a case control study. Logopedics Phoniatrics Vocology, 47 (1), 35-42. https://doi.org/10.1080/14015439.2020.1834614

Bao, Y., Wang, L., Cui, C., Yu, F., Yang, J., & Huang, D. (2024). Bidirectional association between hypothyroidism and myasthenia gravis: a Mendelian randomized study. Neurological Research, 46 (1), 72-80. https://doi.org/10.1080/01616412.2023.2257458

Birnbaum, S., Sharshar, T., Ropers, J., Portero, P., & Hogrel, J. Y. (2023). Neuromuscular fatigue in autoimmune myasthenia gravis: A cross-sectional study. Neurophysiologie Clinique, 53 (4), 1-10. https://doi.org/10.1016/j.neucli.2023.102844

Bogdan, A., Barnett, C., Ali, A., AlQwaifly, M., Abraham, A., Mannan, S., ... & Bril, V. (2020). Prospective study of stress, depression and personality in myasthenia gravis relapses. BMC neurology, 20(1), 1-6. https://doi.org/10.1186/s12883-020-01802-4

Daniëls, M., Van, H. L., van den Heuvel, B., Dekker, J. J., Peen, J., Bosmans, J., ... & Huibers, M. J. (2023). Individual psychotherapy for Cluster-C personality disorders: protocol of a pragmatic RCT comparing short-term psychodynamic supportive psychotherapy, affect phobia therapy and schema therapy (I-FORCE). Trials, 24 (1), 1-21. https://doi.org/10.1186/s13063-023-07136-z

Ensan, N., Rahimian Boogar, I., Talepasand, S., & Estilaee, F. (2020). The effectiveness of mindfulness-based stress reduction in fatigue severity among patients with multiple sclerosis. Studies in Medical Sciences, 31 (2), 137-145. (In Persian) http://umj.umsu.ac.ir/article-1-5010-fa.html

Estévez, D. A. G., & Fernández, J. P. (2023). Myasthenia gravis. Update on diagnosis and therapy. Medicina Clínica, 1 (2), 1-10. https://doi.org/10.1016/j.medcle.2023.04.012

Gazzali, I., Shahin, M. A., Islam, A., Bandhan, I. H., Minhaj, S., Moniruzzaman, M., ... & Zaman, M. M. (2022). Translation, cross-cultural adaptation, and validation of fatigue severity scale into Bangla in patients with systemic lupus erythematosus. Indian Journal of Rheumatology, 17 (3), 1-10. http://dx.doi.org/10.4103/injr.injr_225_21

Gilhus, N. E., Tzartos, S., Evoli, A., Palace, J., Burns, T. M., & Verschuuren, J. J. (2019). Myasthenia gravis. Nature reviews. Disease primers, 5 (1), 30-45. https://doi.org/10.1038/s41572-019-0079-y

GomezMancilla, B., Meriggioli, M. N., Genge, A., Roubenoff, R., Espié, P., Dupuy, C., ... & Gergely, P. (2024). Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study. Journal of Clinical Neuroscience, 119 (1), 76-84. https://doi.org/10.1016/j.jocn.2023.11.013

Habib, A. A., Sacks, N., Cool, C., Durgapal, S., Dennen, S., Everson, K., ... & Phillips, G. (2024). Hospitalizations and Mortality From Myasthenia Gravis: Trends From 2 US National Datasets. Neurology, 102 (2), 1-10. https://doi.org/10.1212/WNL.0000000000207863

Hadeli, M., Peimani, J., Pir Khaefi, A. R., tajvidi, M., & heidari, M. (2022). The effectiveness of schema therapy on executive functions in people with multiple sclerosis (MS). Quarterly of Applide Psychology, 1 (1), 1-10. (In Persian) https://apsy.sbu.ac.ir/article_102734.html

Jiang, J. M., Seng, E. K., Zimmerman, M. E., Sliwinski, M., Kim, M., & Lipton, R. B. (2017). Evaluation of the reliability, validity, and predictive validity of the subscales of the perceived stress scale in older adults. Journal of Alzheimer's Disease, 59 (3), 987-996. https://doi.org/10.3233/jad-170289

Jones, L., Gold, E., Totsika, V., Hastings, R. P., Jones, M., Griffiths, A., & Silverton, S. (2018). A mindfulness parent well-being course: Evaluation of outcomes for parents of children with autism and related disabilities recruited through special schools. European Journal of Special Needs Education, 33 (1), 16-30. https://doi.org/10.1080/08856257.2017.1297571

Kabat‐Zinn, J. (2003). Mindfulness‐based interventions in context: past, present, and future. Clinical psychology: Science and practice, 10 (2), 144-156. https://psycnet.apa.org/doi/10.1093/clipsy.bpg016

Kral, T. R., Davis, K., Korponay, C., Hirshberg, M. J., Hoel, R., Tello, L. Y., & Davidson, R. J. (2022). Absence of structural brain changes from mindfulness-based stress reduction: Two combined randomized controlled trials. Science Advances, 8 (20), 1-10. https://doi.org/10.1126/sciadv.abk3316

Krupp, L. B., LaRocca, N. G., Muir-Nash, J., & Steinberg, A. D. (1989). The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of neurology, 46 (10), 1121-1123. https://doi.org/10.1001/archneur.1989.00520460115022

Liu, C., Chen, H., Cao, X., Sun, Y., Liu, C. Y., Wu, K., ... & Chiou, W. K. (2022). Effects of mindfulness meditation on doctors’ mindfulness, patient safety culture, patient safety competency and adverse event. International journal of environmental research and public health, 19 (6), 1-10. https://doi.org/10.3390/ijerph19063282

Mansourzadeh, A., Shaygannejad, V., Mirmosayyeb, O., Afshari-Safavi, A., & Gay, M. C. (2024). Effectiveness of Schema Therapy on Anxiety, Depression, Fatigue, Quality of Life, and Sleep in Patients with Multiple Sclerosis: A Randomized Controlled Trial. Middle East Journal of Rehabilitation and Health Studies, 11 (1), 1-10. https://doi.org/10.5812/mejrh-132571

Marotta, M., Gorini, F., Parlanti, A., Berti, S., & Vassalle, C. (2022). Effect of Mindfulness-Based Stress Reduction on the Well-Being, Burnout and Stress of Italian Healthcare Professionals during the COVID-19 Pandemic. Journal of Clinical Medicine, 11 (11), 1-10. https://doi.org/10.3390/jcm11113136

Martin, R., & Young, J. (2010). Schema therapy. In K. S. Dobson (Ed.), Handbook of cognitivebehavioral therapies (pp. 317–346). New York, NY: The Guilford Press. https://psycnet.apa.org/record/2010-10108-010

Nazari, A., Saedi, S., & Abdi, M. (2022). The effectiveness of Schema therapy and Acceptance and commitment therapy (ACT) on Chronic fatigue syndrome (CFS) and Health anxiety of patients with Multiple Sclerosis (MS). Medical Journal of Mashhad university of Medical Sciences, 64(6), 4290-4300. (In Persian) https://doi.org/10.22038/mjms.2022.64327.3781

Peeters, N., van Passel, B., & Krans, J. (2022). The effectiveness of schema therapy for patients with anxiety disorders, OCD, or PTSD: A systematic review and research agenda. British Journal of Clinical Psychology, 61 (3), 579-597. https://doi.org/10.1111/bjc.12324

Rose, N., Holdermann, S., Callegari, I., Kim, H., Fruh, I., Kappos, L., & Derfuss, T. (2022). Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities. Acta Neuropathologica, 144 (5), 1005-1025. https://doi.org/10.1007/s00401-022-02493-6

Ruiter, A. M., Verschuuren, J. J., & Tannemaat, M. R. (2021). Prevalence and associated factors of fatigue in autoimmune myasthenia gravis. Neuromuscular Disorders, 31 (7), 612-621. https://doi.org/10.1016/j.nmd.2021.04.002

Sänger, F., Dörfelt, S., Giani, B., Buhmann, G., Fischer, A., & Dörfelt, R. (2024). Successful Emergency Management of a Dog with Ventilator-Dependent Acquired Myasthenia Gravis with Immunoadsorption. Animals, 14 (1), 33-43. https://doi.org/10.3390/ani14010033

Shahvarughi-Farahani, A., A'zimian, M., Fallah-Pour, M., & Karimlou, M. (2013). Evaluation of Reliability and Validity of the Persian Version of Fatigue Severity Scale (FSS) among Persons with Multiple Sclerosis. Archives of Rehabilitation , 13 (4), 84-91. (In Persian) http://rehabilitationj.uswr.ac.ir/article-1-1046-fa.html

Tang, V., Poon, W. S., & Kwan, P. (2015). Mindfulness-based therapy for drug-resistant epilepsy: an assessor-blinded randomized trial. Neurology, 85 (13), 1100-1107. https://doi.org/10.1212/wnl.0000000000001967

Torabi, A.A, Afrooz, G.A, Hassani, F., & Golshani, F. (2021). Designing a Family-Centered Behavioral Management Program (FBMP) and Evaluating its Effectiveness in Marital Satisfaction of Parents of Children with ADHD. Quarterly Journal of Family and Research, 18 (3), 25-42. (In Persian) http://dorl.net/dor/20.1001.1.26766728.1400.18.3.2.5

World Health Organization. (2004). The world health organization quality of life (WHOQOL)-BREF (No. WHO/HIS/HSI Rev. 2012.02). World Health Organization. https://iris.who.int/bitstream/handle/10665/77773/WHO_HIS_HSI_Rev.2012.02_eng.pdf

Yang, X., Zhang, W., Chang, X., Li, Z., Du, R., & Guo, J. (2024). Promising efficacy of Low-Dose rituximab in Muscle specific kinase antibody positive Myasthenia Gravis. Neuroscience Letters, 818 (1), 1-10. https://doi.org/10.1016/j.neulet.2023.137561

Yeşil Demirci, P., Eskimez, Z., & Bozdoğan Yeşilot, S. (2024). The influence of symptom severity and fatigue on sleep quality in patients with myasthenia gravis. Neurological Research, 46 (1), 42-48. https://doi.org/10.1080/01616412.2023.2257449

Young, J. E., Klosko, J. S., & Weishaar, M. E. (2006). Schema therapy: A practitioner's guide. guilford press. https://www.guilford.com/books/Schema-Therapy/Young-Klosko-Weishaar/9781593853723